Novozymes reports tough US bioeconomy conditions hit Q3 sales growth
In Denmark, Novozymes announced organic sales growth for 2019 to date of -2% (Q3: +1%). In its segements, results were: Household Care 0% (Q3: +5%, Food & Beverages -1% (Q3: +1%), Bioenergy -4% (Q3: -5%), Agriculture & Feed -3% (Q3: +3%), Technical & Pharma -3% (Q3: -14%). EBIT margin at 27.6% and net profit down […]











